You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
STTR Phase I: Robotic Leg Advancement Device
SBC: AndrosRobotics LLC Topic: EIThis Small Business Technology Transfer Research (STTR) Phase I project seeks to develop a novel, intelligent device for automation of gait training in the neurological patient population undergoing physical therapy and rehabilitation. The objective of this project is the creation of a physically simple robotic system, which uses a sophisticated control system to intelligently cooperate with the p ...
STTR Phase I 2014 National Science Foundation -
STTR Phase I: Software-Based Building Airflow Analysis Tool for Enabling HVAC Energy Use Savings in Commercial Buildings
SBC: Aeolus Building Efficiency Inc Topic: BCThis Small Business Technology Transfer (STTR) Phase I project will establish proof of concept for a unique, software-based Building Airflow Analysis Tool for measuring and optimizing airflow rates in commercial buildings. Using the existing Building Automation System (BAS), room temperature responses to controlled perturbations of airflow rates are used with a physics-based room thermal model and ...
STTR Phase I 2014 National Science Foundation -
STTR Phase I: Silver Replacement for Conductive Inks
SBC: Microreactor Solutions LLC Topic: NMThis Small Business Innovation Research (SBIR) Phase I project will develop new materials to replace silver in conductive ink applications. Current silver replacement materials all have significant drawbacks making them unsuitable for use in many industries which would benefit from these cost savings. The project will utilize advanced thin film nanocoatings to produce silver replacement materials ...
STTR Phase I 2014 National Science Foundation -
Development of small near-infrared laser system capable of improving immune respo
SBC: SEMINEX CORPORATION Topic: NIAIDDESCRIPTION (provided by applicant): The broad and long-term objective of this project is to amplify the effectiveness of vaccines without the use of chemical or biological adjuvants. We will address this objective by demonstrating the feasibility for small laser- based devices to enhance responses to intradermal vaccination. A number of investigators have shown that a promising new way to make va ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Therapeutic Utility of renalase and renalase peptides in cisplatin-mediated renal
SBC: BESSOR PHARMA, LLC Topic: NCIDESCRIPTION (provided by applicant): Cisplatin is a cornerstone therapy for a number of cancers including testicular, bladder, ovarian and lung. It is also used to treat cancers in children. In all cases there is a high incidence of acute kidney injury (AKI) that can also lead to later stage kidney damage. This risk limits its use. We have found in pilot studies that renalase, or peptide fragment ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Non-ATP competitive inhibitors of cyclin dependent kinases as cancer therapeutics
SBC: PPI PHARMACEUTICALS, LLC Topic: NCIDESCRIPTION (provided by applicant): As cancer is one of the leading causes of death in the United States with some sub-types remaining essentially untreatable, expansion of available drug targets will provide significant new options for the development ofmore effective antineoplastic agents. The major goal of this project is to apply a unique drug discovery strategy to cancer drug development. Th ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
DNP Polarization Agents for Real-Time Metabolic Imaging and Clinical Diagnosis
SBC: DYNUPOL, INC. Topic: NCIProject Summary / Abstract Although standard MRI techniques provide valuable structural insight, a related technique known as magnetic resonance spectroscopy (MRS) adds powerful real-time metabolic information about the tissues under study. MRS provides early detection of disease, monitoring treatment efficacy, and, in the case of cancer, a dramatic reduction in unnecessary biopsies. However, bro ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Developing Inhibitors of the STARS/SRF Pathway for Treatment of Type 2 Diabetes
SBC: Jenesis Biosciences LLC Topic: NIDDKDESCRIPTION (provided by applicant): Type 2 diabetes (T2D) has reached epidemic proportions in the United States, affecting an estimated 8.3% of the population. Unfortunately, the majority of individuals with diabetes continue to have suboptimal control ofglucose, therefore new and improved approaches to prevention and treatment are sorely needed. Dr. Mary Elizabeth Patti's laboratory at the ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
A Millimeter-wave Tunable Cavity for Ultra-sensitive Solids and Liquids DNP-NMR at Low Budget
SBC: DOTY SCIENTIFIC, INC. Topic: NIA? DESCRIPTION (provided by applicant): NMR is probably the most powerful and widely used analytical technique for structure determination and function elucidation of molecules of all types, but it suffers from low sensitivity, particularly for insoluble biological macromolecules. Dynamic Nuclear Polarization (DNP) with Magic Angle Spinning (MAS) has recently demonstrated S/N gains exceeding t ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Novel commensal polysaccharide treats multiple sclerosis through Treg modulation
SBC: SYMBIOTIX BIOTHERAPIES, INC. Topic: NIAIDAbstract Multiple sclerosis (MS) is a chronic demyelinating inflammatory disease that is the most common neurological disease of young adults, affecting over 350,000 patients in the US and over 2.5 million patients worldwide. MS is a disease of high unmetmedical need, currently treatable with one of several approved drugs, all of which result in either immune modulation or significant immunosuppre ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health